Teva Pharmaceutical Industries said that the phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients has yielded positive results. The trial was held […]
Gene therapy-focused biopharma company Orchard Therapeutics has signed a long-term lease agreement to build a third manufacturing facility in Fremont, California. The new facility is expected to open in 2019. The Fremont space will be […]
C4X Discovery (C4XD) and UK-based gene editing company Horizon Discovery Group have forged an exclusive target discovery partnership in oncology. The partnership between C4XD and the Horizon Discovery intends to assess synthetic lethal oncology targets […]
Japan-based Fuji Pharma has acquired a 4.2% stake in biopharmaceutical firm Alvotech for around $50m. Alvotech and Fuji Pharma recently announced an exclusive agreement for development and commercialization of biosimilars in Japan. Fuji´s investment into […]
Vedanta Biosciences, which was founded by PureTech Health, has commenced a phase 2 study of its rationally-defined bacterial consortium product candidate, VE303, for recurrent Clostridium difficile infection (rCDI). VE303 is claimed to be the first […]